NRX Pharmaceuticals Inc

For the period ended Mar 21, 2024. Filed Mar 11, 2024.

About this filing

What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.

Mar 21, 2024 · Filed Mar 11, 2024

Use the contents to explore the available documents and sections.

NRXP$2.38+4.8%Stored close · as of Nov 6, 2026

See the whole filing, with its images and exhibits

Contents

Proxy Statement

March 11, 2024

(484) 254-6134

PROXY STATEMENT

This proxy statement (the “Proxy Statement”), the attached Notice of Special Meeting of Stockholders (the “Notice”) and the enclosed proxy card are being mailed to stockholders of record on or about March 11, 2024 and are furnished in connection with the solicitation of proxies by the Board of Directors (the “Board”) of NRx Pharmaceuticals, Inc. (the “Company,” “we,” or “us”) for use at our Special Meeting of Stockholders (the “Special Meeting”), to be held on March 21, 2024, at 11:00 a.m., Eastern Time, in virtual-only format athttps://www.cstproxy.com/nrxpharma/sm2024, and at any adjournments or postponements thereof.

IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE STOCKHOLDER MEETING TO BE HELD ON MARCH 21, 2024

This Proxy Statement is available for viewing, printing and downloading atwww.nrxpharma.com

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.